94%Confidence
0Views
FDASource
2026-03-11Date
Summary
Recall of lubricant eye drops due to lack of sterility assurance further implicates Omni Lens as a manufacturer with recurring cGMP violations. This pattern threatens the reliability of multiple ophthalmic product lines under the Vista brand and associated distributors.
Actionable: Investigate the financial and operational impact on distributors like hi-health and consider diversifying away from Omni Lens-sourced ophthalmic products.
AI Confidence: 94%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manuf
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now